Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-53734
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
dawa-pharma-1.0 - SQL Injection via Email Parameter
Source: NVD (National Vulnerability Database)
Vulnerability Description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
SQL命令中使用的特殊元素转义处理不恰当(SQL注入)
Source: NVD (National Vulnerability Database)
Vulnerability Title
Mayurik dawa-pharma SQL注入漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Mayurik dawa-pharma是Mayurik开源的一个药房管理系统。 Mayurik dawa-pharma 1.0版本存在SQL注入漏洞,该漏洞源于未经验证的攻击者可执行SQL查询,可能导致敏感信息泄露和获取管理员权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
mayurikdawa-pharma 1.0-2022 -
II. Public POCs for CVE-2023-53734
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-53734
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2023-53734

No comments yet


Leave a comment